Haleon plc (LON:HLN)
London
· Delayed Price · Currency is GBP · Price in GBX 367.40
-4.80 (-1.29%)
Jul 11, 2025, 4:37 PM BST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Oral Health | 3.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oral Health Growth | 5.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Vitamins, Minerals and Supplement | 1.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Vitamins, Minerals and Supplement Growth | 1.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pain Relief | 2.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pain Relief Growth | -1.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Respiratory Health | 1.68B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Respiratory Health Growth | -1.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Digestive Health and Other | 1.98B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Digestive Health and Other Growth | -9.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
North America | 4.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Growth | -2.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA & LatAm | 4.63B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA & LatAm Growth | -0.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC | 2.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC Growth | 1.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
North America Adjusted Operating Profit | 1.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA & LatAm Adjusted Operating Profit | 1.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA & LatAm Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC Adjusted Operating Profit | 539.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Adjusted Operating Profit | -93.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Organic Revenue Growth | 5.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales Growth due to Price | 3.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales Growth due to Volume/Mix | 1.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|